# The nuclear factor E2-related factor 2 and age-related macular degeneration

**Authors:** Rogil José de Almeida Torres, Rogério João de Almeida Torres, Andréa Luchini, Ana Lúcia dos Anjos Ferreira

PMC · DOI: 10.5935/0004-2749.20230024 · Arquivos Brasileiros de Oftalmologia · 2022-02-18

## TL;DR

This paper explores how the nuclear factor E2-related factor 2 helps prevent age-related macular degeneration by maintaining redox balance.

## Contribution

The paper highlights the role of nuclear factor E2-related factor 2 in preserving vision through antioxidant enzymes.

## Key findings

- Nuclear factor E2-related factor 2 is crucial for maintaining redox balance.
- Its activation leads to antioxidant enzymes that prevent macular degeneration.
- Understanding this pathway may aid in developing new treatments for vision loss.

## Abstract

After the discovery of anti-vascular endothelial growth factor agents as
treatment of wet age-related macular degeneration, the number of studies with
the objective to understand the molecular mechanisms involved in the age-re
lated macular degeneration genesis has increased. The importance of the nuclear
factor e2-related factor 2 lies in its activation-derived proteins being
involved in the maintenance of the redox balance and consequent prevention of
degenerative macular disease. This article aims to present the characteristics
of nuclear factor e2-related factor 2 and describe the main nuclear factor
e2-related factor 2-activated antioxidant enzymes that contribute to the
preservation of vision.

## Linked entities

- **Diseases:** age-related macular degeneration (MONDO:0005150)

## Full-text entities

- **Genes:** VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}
- **Diseases:** degenerative macular disease (MESH:D019636), age-related macular degeneration (MESH:D008268),  (MESH:D057135)
- **Chemicals:**  (MESH:D020533)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11892469/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11892469/full.md

## References

115 references — full list in the complete paper: https://tomesphere.com/paper/PMC11892469/full.md

---
Source: https://tomesphere.com/paper/PMC11892469